🚨 IVERMECTIN + MEBENDAZOLE CANCER STUDY: THE 84.4% NUMBER HAS A BIG CATCH A creator says they're willing to admit they were wrong about Ivermectin and cancer, then takes a closer look at the new study that reported an 84.4% Clinical Benefit Ratio. At first glance, the result